je.st
news
Tag: presents results
Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015
2015-06-01 12:09:35| Logistics - Topix.net
Mirati Therapeutics, Inc. today presented data that demonstrated preliminary evidence of clinical activity from its investigational targeted tyrosine kinase inhibitor candidate, MGCD265, as part of the developmental therapeutics category at the 2015 American Society of Clinical Oncology Annual Meeting being held in Chicago from May 29-June 2, 2015. The Company also provided updates on its other targeted tyrosine kinase inhibitor, MGCD516, and spectrum-selective HDAC inhibitor, mocetinostat.
Tags: results
presents
preliminary
inhibitor
DRIVE C2X presents results of large-scale connected vehicle field testing in Europe
2014-07-16 19:30:40| Green Car Congress
Tags: results
field
drive
europe
Compugen Presents Experimental Results Supporting Induction of Immune ...
2013-10-17 10:04:51| Biotech - Topix.net
In a presentation tomorrow at the Autoimmune & Inflammation Leaders' Forum in Boston, Massachusetts, Galit Rotman, PhD, Chief Scientist of Therapeutics at Compugen Ltd. , will disclose results from an animal model study in which CGEN-15001, an Fc fusion protein drug candidate derived from a novel immune checkpoint protein discovered by Compugen, ... (more)
Tags: results
presents
supporting
experimental
TowerJazz Presents First Quarter 2013 Results and Second Quarter Guidance
2013-05-09 22:31:20| Electronics - Topix.net
Reduced 2013 and 2014 principal payments from $105 million to $30 million, extending a low interest of LIBOR+3.5 percent bank loan to final maturity in 2016; Russell Ellwanger, Chief Executive Officer of TowerJazz, commented : "We leave first quarter confident in our tactics and strategies, demonstrated by quarter over quarter double digit guidance ... (more)
Tags: results
presents
quarter
guidance
TowerJazz Presents First Quarter 2013 Results and Second Quarter Guidance
2013-05-09 12:12:27| Semiconductors - Topix.net
Reduced 2013 and 2014 principal payments from $105 million to $30 million, extending a low interest of LIBOR+3.5 percent bank loan to final maturity in 2016; Russell Ellwanger, Chief Executive Officer of TowerJazz, commented : "We leave first quarter confident in our tactics and strategies, demonstrated by quarter over quarter double digit guidance ... (more)
Tags: results
presents
quarter
guidance
Sites : [1] [2]